MétaCan
Menu
Back to cohort
Record W4408562540 · doi:10.1101/2025.03.17.25324125

Simulation Models for Bladder Cancer: A Scoping Review

2025· review· en· W4408562540 on OpenAlexaff
Stavroula A. Chrysanthopoulou, Timothy Hedspeth, Dana Antinozzi, Yullia Sereda, Hawre Jalal, Thomas A Trikalinos, John B. Wong, Stella K. Kang

Bibliographic record

VenuemedRxiv · 2025
Typereview
Languageen
FieldMathematics
TopicMathematical Biology Tumor Growth
Canadian institutionsUniversity of Ottawa
Fundersnot available
KeywordsBladder cancerComputer scienceSystematic reviewLimitingMedicineScope (computer science)MEDLINEPsychological interventionMedical physicsModalitiesManagement scienceData scienceCancerBiologyEngineeringInternal medicine

Abstract

fetched live from OpenAlex

Objectives: The study identifies and summarizes information from manuscripts using simulation models for Bladder Cancer (BCA) research. Methods: We conducted and presented results of a systematic literature search of Medline, Web of Science, and Google scholar, following the PRISMA guidelines for scoping reviews. We summarized extracted key components of the methodology, data sources, and software used for the development of simulation models and classify eligible articles in terms of the study objectives and conclusions. Results: The 97 identified modeling studies simulating aspects of BCA included models that (1) describe the biological process of carcinogenesis and tumor progression (mostly compartmental models); (2) examine the impact of screening protocols and interventions on disease progression and prognosis (mostly microsimulation models); and (3) assess the cost-effectiveness of BCA treatment and control strategies (cohort-based simulation models or simpler decision tree structures). The scope, objectives, and conclusions of these studies varied substantially. Most focused on evaluating treatments, mostly for non-muscle invasive bladder cancer, with some examining BCA screening and surveillance. Their objectives, methods, and analyses were inconsistently and often incompletely reported. Conclusions: Simulation models in bladder cancer examine questions that span the range from tumor kinetics to cost effectiveness of tumor management, but shortcomings in their reporting hinder assessments of their applicability and methodological rigor, severely limiting their practical usefulness. Highlight statements: We assessed the available landscape of simulation modeling for health decision making in BCA research.Shortcomings in the reporting of this research severely limit their practical usefulness.Future population modeling should assess BCA screening and surveillance. Strengths: This is the first, to our knowledge, systematic appraisal of simulation models in bladder cancer. Simulation modeling will be a key technology to assess the utility of highly promising novel diagnostics and treatments, while evidence accumulates.The described variation in the objectives, methodological rigor, and reporting of models' development, validation, and analysis likely generalize to other disease areas. Limitations: This descriptive compendium does not explicitly compare the results of different models between them or with observed data.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.024
metaresearch head score (Gemma)0.102
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.024
Threshold uncertainty score0.125

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0240.102
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0050.009
Bibliometrics0.0130.014
Science and technology studies0.0010.001
Scholarly communication0.0050.003
Open science0.0030.002
Research integrity0.0040.003
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.227
GPT teacher head0.484
Teacher spread0.257 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venuemedRxivSame topicMathematical Biology Tumor GrowthFrench-language works237,207